As a treatment option for near vision loss, or presbyopia, the KAMRA corneal inlay is designed to create a small aperture effect for the eye, allowing patients to see near and intermediate objects more clearly.

The AcuTarget system is an exclusive and patented technology used to guide surgeons on proper surgical placement of the KAMRA inlay.

According to the company, presbyopia affects more than 1.5 billion people globally. Until now patients could only treat presbyopia or near vision loss with reading glasses, contact lenses or LASIK. However, these options come with compromise, such as significant loss of distance and intermediate vision.

The KAMRA inlay offers patients a new alternative, which significantly reduces dependence on reading glasses while maintaining a full range of vision.

The KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The KAMRA inlay is placed under a LASIK-type flap using the AcuTarget System, said AcuFocus.

The AcuTarget System is an exclusive and patented technology used to guide surgeons on proper surgical placement of the KAMRA inlay, ensuring precise, predictable and repeatable implantation for best outcomes and overall patient satisfaction.

The KAMRA inlay received CE mark for use in the EU in 2005 and is an investigational device under Investigational Device Exemption (IDE) in the US.

Presbyopia, a part of the normal aging process, reduces the ability of the eye to focus on near objects. This condition occurs when the crystalline lens of the eye loses its flexibility, making it difficult to focus on close objects.

Mike Judy, chief commercialization officer at AcuFocus, said: “The strong interest that we see from leading ophthalmic practices around the world underscores the potential of the KAMRA inlay to truly change the paradigm in presbyopia treatment.

“The KAMRA inlay and the AcuTarget system offer eye care professionals a proven, precise and predictable solution for presbyopia, virtually eliminating a patient’s need for reading glasses.”

Will the new product benefit presbyopia patients?

Have your say and discuss with your peers on the InfoGrok community.

Participate by posting your comments now.